House committee launches investigation into Eli Lilly’s China clinical trials at military hospitals and Xinjiang facilities, citing biotech risks.
Featured Posts Title
China’s birth crisis threatens Xi’s superpower dream
Analysis-China draws ‘red lines’ around its economic model ahead of EU, US trade talks
US companies win billions in African data center deals in direct competition with China
China’s Digital Gaze: How Beijing Tracks Foreigners Down To Their Gas Bills
Beijing warns Manila of ‘powerful’ South China Sea toolbox ready for ‘head-on blow’
Washington Wants Iraq, But Tehran And Beijing Won’t Let Go
A young Tibetan flees his homeland – and reveals how China is eroding his culture
Recent Posts
Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals
China Resources New Energy, Asia’s biggest IPO this year, to debut July 2
BEIJING, June 30 (Reuters) – China Resources New Energy will start trading in Shenzhen on July 2 after an initial public offering that could raise up to 24.5 billion yuan ($3.6 billion), setting up …
Chinese AI and chip firms fuel China’s 2026 onshore IPO rebound
China’s AI and chip firms revive onshore IPOs in 2026 as Beijing pushes tech self-reliance and funding routes for hard-tech startups.
Guo Wengui: Beijing Responds to US Jailing CCP Critic With Trump Links
Beijing has responded to the sentencing of Guo Wengui, a Chinese tycoon, self-styled dissident and close ally of U.S. President Donald Trump’s strategist Steve Bannon. Guo, 57, was sentenced to 30 …
China responds after Steve Bannon ally Guo Wengui sentenced to 30 years
Guo Wengui teamed up with Steve Bannon on anti-Communist Party projects before the massive fraud case.
China Hails Breakthrough in ‘Artificial Sun’ Project
Reactor-scale magnets successfully contained 100 million-degree Fahrenheit plasma, edging commercial fusion energy a step closer.
China claims major breakthrough in “artificial sun” fusion project
Reactor-scale magnets successfully contained 100 million-degree Fahrenheit plasma, edging commercial fusion energy a step closer.
Eli Lilly transfers commercialization rights for breast cancer drug in China
By Andrew Silver SHANGHAI, June 30 (Reuters) – Eli Lilly has transferred the mainland China commercialization rights for its breast cancer drug Verzenios to Innovent Biologics, the Chinese drugmaker …
Retailers front-loading Chinese imports to beat looming July 24 tariff deadline
To get ahead of potentially higher import tariffs later this summer, U.S. retailers are stocking up on Chinese goods, bringing holiday-related orders up by four to six weeks. “There is an expectation …
China lifts restrictions on oil-product exports, raising July quota to 800,000 metric tons
China raises refined oil export quota to 800,000 metric tons for July, up from 600,000 in June, easing restrictions imposed during the Iran conflict.
China’s Latest Pressure Tactics Are Tightening the Screws on Japan
Beijing’s moves have included flying bombers near Japan, detaining businesspeople and restricting the exports of rare earths.
China central bank doubles overnight cash injection, keeps rate unchanged, sources say
June 30 (Reuters) – China’s central bank ramped up liquidity injections on Tuesday, doubling the amount of cash supplied through overnight reverse repos as seasonal month-end demand intensified. The …
The luxury market is poised for a comeback by 2030 – here’s what US and China clients want
A new McKinsey and Business of Fashion report reveals how aspirational spending, emotional connection and experience are reshaping the luxury sector.
